Targepeutics
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We have also licensed related technology for a cancer immunotherapy that is in Phase clinical trials.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Targepeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- LM
Lynn Maines
Vice President · General Business & Management
EmailPhone - RS
Randy Schrecengost
Chief Scientific Officer · Research & Development
EmailPhone - SL
Sil Lutkewitte
Chief Executive Officer · General Business & Management
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Targepeutics
3 distinct titles indexed · top 3 shown.
- 1chief executive officer
- 1chief scientific officer
- 1vice president
Sign up to unlock all 3 contacts at Targepeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Targepeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.